Press Service

The European Union is committed to fighting climate change and the destruction of the environment and transitioning to a modern and competitive economy that makes efficient use of its resources. Yet technologies such as artificial intelligence have the potential to do as much harm as good. For instance, although AI applications can help reduce environmental pollution in agriculture, they expend significant computing resources, causing additional harm to people and the environment. The University of Bonn is assuming overall leadership of the RE4GREEN project, which is designed to focus on climate and environmental ethics during this upcoming transition. The initiative is to receive a total of €3 million in EU funding over the next three years.

Our lungs are bombarded by all manner of different particles every single day. Whilst some are perfectly safe for us, others—known as pathogens—have the potential to make us ill. The immune system trains its response whenever it encounters such a pathogen. Yet researchers at the University of Bonn have now shown that even harmless particles help to improve the immune response and have published their results in the journal “Nature Immunology.”

Chemokines are signalling proteins that orchestrate the interaction of immune cells against pathogens and tumours. To understand this complex network, various techniques have been developed to identify chemokine-producing cells. However, it has not yet been possible to determine which cells react to these chemokines. Researchers at the University Hospital Bonn (UKB) and the University of Bonn have developed a new class of genetically modified mice that enables the simultaneous identification of chemokine producers and sensors. Using the chemokine Ccl3 as a “proof of principle”, they discovered that its function in the immune defence against viruses is different than had been previously assumed. Their results have now been published in the "Journal of Experimental Medicine".

Uveitis is a rare inflammatory eye disease. Posterior and panuveitis in particular are associated with a poor prognosis and a protracted course of the disease. Diagnosis and monitoring can be challenging for healthcare professionals. Fundus autofluorescence (FAF) is a fast and non-invasive imaging technique that supports this. Researchers from the University Hospital Bonn and the University of Bonn, together with experts from Berlin, Münster and Mannheim, have drafted a review on how FAF can facilitate the diagnosis and monitoring of posterior uveitis and panuveitis. The results have now been published in the journal "Biomolecules".